On the morning of July 4, 2024, a grand signing ceremony between Neuboron and Digital Sea Park was held at the G60 Science and Innovation Cloud Corridor Reception Hall. Distinguished guests attending the ceremony included Liu Wei, Member of the Party Committee and Vice President of Lingang Group; Liu Dehong, Secretary of the Party Committee and President of Lingang Holdings, and Secretary of the Party Committee and Chairman of Lingang United Company; Tong Junxin, Director of the Science and Innovation Management Department of Lingang Group; Yang Lingyu, Deputy Secretary of the Party Committee and General Manager of Lingang United Company, and Chairman of Digital Sea Company; as well as Professor Liu Yuanhao, Founder and CEO of Neuboron.
As a world-leading enterprise in Boron Neutron Capture Therapy (BNCT), Neuboron boasts world-class R&D and production capabilities for BNCT drugs and equipment, and has overcome multiple key technical challenges in the industry. The company provides comprehensive BNCT solutions covering hardware, software, and drugs.
Liu Wei stated that Neuboron's BNCT products represent a transformative technology that benefits both the country and its people, and will inject new vitality and momentum into the biomedical industry of the park.
Through this cooperation, Digital Sea Park has clearly identified precision medicine as its advantageous industry. Since its launch, the park has received significant attention from municipal and district governments, Lingang Group, and all sectors of society. Committed to becoming a fertile ground for enterprise innovation and development, Digital Sea Park will continuously optimize the business environment, enhance service efficiency, and strive to build digital innovation advantages.
Lingang Group and Fengxian District will provide all-round support for the development of Neuboron's BNCT industry, forming a close strategic partnership to jointly build a world-class BNCT industrial cluster in Digital Sea, and fully implement Shanghai's industrial layout in precision medicine and advanced manufacturing.
Professor Liu Yuanhao, CEO of Neuboron, said, "We are honored to cooperate with Digital Sea Park to promote the development of BNCT technology. This signing is not only a significant milestone in the development of Neuboron, but also an important manifestation of our practice of the core values of 'Be light Be salt. Treat patients as our family.' and the realization of our corporate goal of ‘Make a real CHANGE in cancer treatment'. We believe that with joint efforts, Neuboron will achieve greater breakthroughs in precision medicine and bring hope to more patients."
The cooperation between Digital Sea Park and Neuboron will promote the industrialization of Neuboron's BNCT equipment. The two parties have set 4 timelines and 21 work items in the strategic agreement, with practical measures to ensure the smooth progress of the project.
This signing ceremony marks the official launch of cooperation between Neuboron and Digital Sea Park. In the future, the two parties will work hand in hand to make positive contributions to the development of the biomedical industry.
